Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced ...

Industry professionals react to OpenAI models hacking Hugging Face, debating whether it was a failure or unprecedented ...

Thousands of U.S. and allied troops recently converged on the California desert to stress-test artificial intelligence-driven ...

SayGames uses player data and testing to balance difficulty in hybrid puzzle games. Finding the right balance between challenge, retention and monetisation requires continuous testing and iteration.

Q3 2026 Earnings Call July 29, 2026 4:15 PM EDTCompany ParticipantsCatherine Park - Vice President of Investor ...

Turkey’s Navy is set to receive 100 expendable one-way unmanned surface vessels designed to strike targets in coordinated ...

Atlys is changing the visa application process by eliminating uncertainty and building trust with travelers. Discover how the ...

Assisted reproductive technologies (ART) have transformed infertility treatment from a medical intervention into a global ...

Objective The objective of this study was to investigate treatment outcomes and identify factors associated with recovery among children aged 6–59 months with severe acute malnutrition who were ...

Abstract: Representing the 3-D environment with instance-aware semantic and geometric information is crucial for interaction-aware robots in dynamic environments. Nevertheless, creating such a ...

Clip of Dr. Peter Attia: Is it science fiction to imagine that there will be a day when an A.I. can predict 20 years in ...

Inhibrx Biosciences' cash runway is tight, with $261.7M cash, $275M debt, and further financing options uncertain. Learn why ...